Screening and Preliminary Identification of Inhibin α Subunit-Specific Nanobodies Through High-Throughput Sequencing Combined with Mass Spectrometry.

For inhibin B, a decreasing trend was observed in the Nb-1737 group, but it did not reach statistical significance, and no differences were noted in the other treatment groups ( Figure 7 N). 4.

also in 47,180 other papers